Author:
Abbas Shania,Raza Syed Tasleem,Ahmed Faisal,Ahmad Absar,Rizvi Saliha,Mahdi Farzana
Abstract
Abstract
Type 2 diabetes mellitus (T2DM) is a non-autoimmune, complex, heterogeneous and polygenic metabolic disease condition characterized by persistent elevated blood glucose levels (hyperglycemia). India as said to be the diabetic capital of the world is likely to experience the largest increase in T2DM and a greater number of diabetic individuals in the world by the year 2030. Identification of specific genetic variations in a particular ethnic group has a critical role in understanding the risk of developing T2DM in a much efficient way in future. These genetic variations include numerous types of polymorphisms among which single nucleotide polymorphisms (SNPs) is the most frequent. SNPs are basically located within the regulatory elements of several gene sequences. There are scores of genes interacting with various environmental factors affecting various pathways and sometimes even the whole signalling network that cause diseases like T2DM. This review discusses the biomarkers for early risk prediction of T2DM. Such predictions could be used in order to understand the pathogenesis of T2DM and to better diagnostics, treatment, and eventually prevention.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Biochemistry, medical,Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference103 articles.
1. Snehalatha , Ramachnadaran : Conference in Centre for Cellular and Molecular Biology. Insight into the Mechanism of Primary Prevention of Type 2 Diabetes: Improvement in Insulin Sensitivity and Beta cell function. “Genetic and Epigenetic Basis of Complex Diseases. 2009
2. Hoskote SS, Joshi SR: Are Indians destined to be diabetic. J Assoc Physicians India. 2008, 56: 225-226.
3. Das SK: Genetic epidemiology of adult onset type 2 diabetes in asian indian population: past, present and future. Int J Hum Genet. 2006, 6 (1): 1-13.
4. Barroso I, Gurnell M, Crowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GL, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature. 1999, 402 (6764): 880-3.
5. Altshuler D, Hirchhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES: The common PPAR Pro12Ala polymorphism in associated with decreased risk of type 2 diabetes. Nat Genet. 2000, 26: 76-80.
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献